[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.5352/JLS.2011.21.3.417

Analysis of the Expression Patterns of Thymosin β4, Vascular Endothelial Growth Factor, and Hypoxia-Inducible Factor-1α in Various Tumors Using Tissue Microarray

Lee, Bo-Young (Department of Parasitology and Gnenetics, Kosin University College of Medicine)
Lee, Seung-Hyun (Department of Surgery, Kosin University College of Medicine)
Ahn, Byung-Kwon (Department of Surgery, Kosin University College of Medicine)
Ock, Mee-Sun (Department of Parasitology and Gnenetics, Kosin University College of Medicine)
Cha, Hee-Jae (Department of Parasitology and Gnenetics, Kosin University College of Medicine)

Publication Information

Journal of Life Science / v.21, no.3, 2011 , pp. 417-423 More about this Journal

Abstract

Thymosin ${\beta}4$ (TB-4) has been reported to play a key role in tumor growth, metastasis and angiogenesis. In addition, TB-4 induced the expression of vascular endothelial growth factor (VEGF) and stabilized the hypoxia-inducible factor (HIF)- $1{\alpha}$ in melanoma cells. Although the importance of thymosin ${\beta}4$ in angiogenesis and metastasis has been proven, there are few studies that show the expression patterns of TB-4, VEGF and HIF- $1{\alpha}$ . This study was conducted to analyze the relationship among these proteins in various tumors. Using tissue microarray analysis, we investigated the expression patterns of TB-4, VEGF and HIF- $1{\alpha}$ in various tumors to identify the expression patterns and relationships of these proteins in certain tumors. TB-4 was highly expressed in osteosarcoma, colon adenocarcinoma, esophageal squamous cell carcinoma, kidney and urinary bladder transitional carcinoma, lung cancer, and liver cancer. HIF- $1{\alpha}$ was highly expressed in nasal cavity inverted papilloma, lung cancer, and esophageal squamous cell carcinoma. The expression patterns of TB-4 and HIF- $1{\alpha}$ were almost similar and co-localized. VEGF expression was high in the blood vessels in tumors, but usually not high in the tumors themselves. VEGF was moderately expressed in stomach cancer, liver angiosarcoma, gall bladder adenocarcinoma, and uterus endometrial adenocarcinoma. The expression patterns of VEGF shows similarities in certain tumors including stomach cancer, osteosarcoma, liposarcoma, lung cancer, liver cancer, gall bladder adenocarcinoma, esophageal squamous cell carcinoma, stomach cancer, colorectal carcinoma and renal cell carcinoma. These results suggest that the expression patterns of TB-4, HIF- $1{\alpha}$ and VEGF were co-localized and related to tumorigenesis and angiogenesis of certain tumors.

Keywords

Thymosin ${\beta}4$ ; VEGF; HIF- $1{\alpha}$ ; tissue microarray; various tumors;

Citations & Related Records

Reference

1	Low, T. L., S. K. Hu, and A. L. Goldstein. 1981. Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc. Natl. Acad. Sci. USA 78, 1162-1166. DOI
2	Malinda, K. M., A. L. Goldstein, and H. K. Kleinman. 1997. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 11, 474-481.
3	Malinda, K. M., G. S. Sidhu, H. Mani, K. Banaudha, R. K. Maheshwari, A. L. Goldstein, and H. K. Kleinman. 1999. Thymosin beta4 accelerates wound healing. J. Invest. Dermatol. 113, 364-368. DOI
4	Philp, D., A. L. Goldstein, and H. K. Kleinman. 2004. Thymosin beta 4 promotes angiogenesis, wound healing, and hair follicle development. Mech. Ageing Dev. 125, 113-115. DOI
5	Bock-Marquette, I., A. Saxena, M. D. White, J. M. Dimaio, and D. Srivastava. 2004. Thymosin beta4 activates integrin- linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432, 466-472. DOI
6	Cha, H. J., M. J. Jeong, and H. K. Kleinman. 2003. Role of thymosin beta4 in tumor metastasis and angiogenesis. J. Natl. Cancer Inst. 95, 1674-1680. DOI ScienceOn
7	Grant, D. S., W. Rose, C. Yaen, A. Goldstein, J. Martinez, and H. Kleinman. 1999. Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3, 125-135. DOI
8	Sanders, M. C., A. L. Goldstein, and Y. L. Wang. 1992. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc. Natl. Acad. Sci. USA 89, 4678-4682. DOI
9	Philp, D., M. Nguyen, B. Scheremeta, S. St-Surin, A. M. Villa, A. Orgel, H. K. Kleinman, and M. Elkin. 2004. Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J. 18, 385-387.
10	Philp, D., S. St-Surin, H. J. Cha, H. S. Moon, H. K. Kleinman, and M. Elkin. 2007. Thymosin beta 4 induces hair growth via stem cell migration and differentiation. Ann. N.Y. Acad. Sci. 1112, 95-103. DOI ScienceOn
11	Wang, W. S., P. M. Chen, H. L. Hsiao, H. S. Wang, W. Y. Liang, and Y. Su. 2004. Overexpression of the thymosin beta- 4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 23, 6666-6671. DOI
12	Huang, H. C., C. H. Hu, M. C. Tang, W. S. Wang, P. M. Chen, and Y. Su. 2007. Thymosin beta4 triggers an epithelial- mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene 26, 2781-2790. DOI
13	Ji, P., S. Diederichs, W. Wang, S. Boing, R. Metzger, P. M. Schneider, N. Tidow, B. Brandt, H. Buerger, E. Bulk, M. Thomas, W. E. Berdel, H. Serve, and C. Muller-Tidow. 2003. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041. DOI
14	Jo, J. O., S. R. Kim, M. K. Bae, Y. J. Kang, M. S. Ock, H. K. Kleinman, and H. J. Cha. 2010. Thymosin beta4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1alpha-dependent manner. Biochim. Biophys. Acta 1803, 1244-1251. DOI ScienceOn
15	Larsson, L. I. and S. Holck. 2007. Localization of thymosin beta-4 in tumors. Ann. N.Y. Acad. Sci. 1112, 317-325. DOI
16	Kallio, P. J., I. Pongratz, K. Gradin, J. McGuire, and L. Poellinger. 1997. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl. Acad. Sci. USA 94, 5667-5672. DOI
17	Kallio, P. J., W. J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger. 1999. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525. DOI
18	Kobayashi, T., F. Okada, N. Fujii, N. Tomita, S. Ito, H. Tazawa, T. Aoyama, S. K. Choi, T. Shibata, H. Fujita, and M. Hosokawa. 2002. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am. J. Pathol. 160, 869-882. DOI
19	Larsson, L. I. and S. Holck. 2007. Occurrence of thymosin beta4 in human breast cancer cells and in other cell types of the tumor microenvironment. Hum. Pathol. 38, 114-119. DOI